vs

Side-by-side financial comparison of BLACKBAUD INC (BLKB) and INSMED Inc (INSM). Click either name above to swap in a different company.

BLACKBAUD INC is the larger business by last-quarter revenue ($281.1M vs $263.8M, roughly 1.1× INSMED Inc). BLACKBAUD INC runs the higher net margin — 11.1% vs -124.5%, a 135.6% gap on every dollar of revenue. On growth, INSMED Inc posted the faster year-over-year revenue change (152.6% vs 4.2%). BLACKBAUD INC produced more free cash flow last quarter ($37.0M vs $-264.2M). Over the past eight quarters, INSMED Inc's revenue compounded faster (86.9% CAGR vs -1.1%).

Blackbaud, Inc. is a cloud computing provider that supports nonprofits, foundations, corporations, education institutions, healthcare organizations, religious organizations, and individual change agents. Its products focus on fundraising, website management, CRM, analytics, financial management, ticketing, and education administration.

Insmed Inc. is a global biopharmaceutical firm focused on developing and commercializing innovative therapies for patients with serious rare diseases that have high unmet medical needs. Its key offerings target pulmonary and endocrine rare disorders, serving markets across North America, Europe, and Asia Pacific.

BLKB vs INSM — Head-to-Head

Bigger by revenue
BLKB
BLKB
1.1× larger
BLKB
$281.1M
$263.8M
INSM
Growing faster (revenue YoY)
INSM
INSM
+148.5% gap
INSM
152.6%
4.2%
BLKB
Higher net margin
BLKB
BLKB
135.6% more per $
BLKB
11.1%
-124.5%
INSM
More free cash flow
BLKB
BLKB
$301.2M more FCF
BLKB
$37.0M
$-264.2M
INSM
Faster 2-yr revenue CAGR
INSM
INSM
Annualised
INSM
86.9%
-1.1%
BLKB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BLKB
BLKB
INSM
INSM
Revenue
$281.1M
$263.8M
Net Profit
$31.1M
$-328.5M
Gross Margin
59.2%
83.2%
Operating Margin
18.3%
-121.2%
Net Margin
11.1%
-124.5%
Revenue YoY
4.2%
152.6%
Net Profit YoY
620.3%
-39.5%
EPS (diluted)
$0.67
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLKB
BLKB
INSM
INSM
Q1 26
$281.1M
Q4 25
$295.3M
$263.8M
Q3 25
$281.1M
$142.3M
Q2 25
$282.0M
$107.4M
Q1 25
$269.9M
$92.8M
Q4 24
$302.1M
$104.4M
Q3 24
$286.6M
$93.4M
Q2 24
$287.3M
$90.3M
Net Profit
BLKB
BLKB
INSM
INSM
Q1 26
$31.1M
Q4 25
$36.7M
$-328.5M
Q3 25
$47.5M
$-370.0M
Q2 25
$26.5M
$-321.7M
Q1 25
$4.3M
$-256.6M
Q4 24
$-346.4M
$-235.5M
Q3 24
$18.3M
$-220.5M
Q2 24
$21.2M
$-300.6M
Gross Margin
BLKB
BLKB
INSM
INSM
Q1 26
59.2%
Q4 25
58.3%
83.2%
Q3 25
59.6%
79.4%
Q2 25
59.7%
73.9%
Q1 25
57.5%
77.1%
Q4 24
53.8%
75.0%
Q3 24
54.9%
77.3%
Q2 24
56.0%
76.8%
Operating Margin
BLKB
BLKB
INSM
INSM
Q1 26
18.3%
Q4 25
20.0%
-121.2%
Q3 25
19.4%
-257.1%
Q2 25
20.3%
-291.3%
Q1 25
7.3%
-267.3%
Q4 24
-121.5%
-220.6%
Q3 24
14.4%
-228.4%
Q2 24
14.4%
-319.8%
Net Margin
BLKB
BLKB
INSM
INSM
Q1 26
11.1%
Q4 25
12.4%
-124.5%
Q3 25
16.9%
-260.0%
Q2 25
9.4%
-299.5%
Q1 25
1.6%
-276.4%
Q4 24
-114.6%
-225.5%
Q3 24
6.4%
-236.0%
Q2 24
7.4%
-332.8%
EPS (diluted)
BLKB
BLKB
INSM
INSM
Q1 26
$0.67
Q4 25
$0.75
$-1.55
Q3 25
$0.98
$-1.75
Q2 25
$0.55
$-1.70
Q1 25
$0.09
$-1.42
Q4 24
$-6.82
$-1.30
Q3 24
$0.35
$-1.27
Q2 24
$0.41
$-1.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLKB
BLKB
INSM
INSM
Cash + ST InvestmentsLiquidity on hand
$34.1M
$1.4B
Total DebtLower is stronger
$546.8M
Stockholders' EquityBook value
$34.6M
$739.0M
Total Assets
$2.1B
$2.3B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLKB
BLKB
INSM
INSM
Q1 26
$34.1M
Q4 25
$38.9M
$1.4B
Q3 25
$38.3M
$1.7B
Q2 25
$41.6M
$1.9B
Q1 25
$37.2M
$1.2B
Q4 24
$67.6M
$1.4B
Q3 24
$34.6M
$1.5B
Q2 24
$30.4M
$1.2B
Total Debt
BLKB
BLKB
INSM
INSM
Q1 26
Q4 25
$1.1B
$546.8M
Q3 25
$546.8M
Q2 25
$546.8M
Q1 25
$1.1B
Q4 24
$1.1B
$1.1B
Q3 24
$1.0B
$971.8M
Q2 24
$1.0B
$1.2B
Stockholders' Equity
BLKB
BLKB
INSM
INSM
Q1 26
$34.6M
Q4 25
$85.1M
$739.0M
Q3 25
$108.2M
$945.6M
Q2 25
$72.7M
$1.2B
Q1 25
$17.5M
$99.2M
Q4 24
$126.8M
$285.4M
Q3 24
$544.8M
$483.4M
Q2 24
$577.5M
$38.8M
Total Assets
BLKB
BLKB
INSM
INSM
Q1 26
$2.1B
Q4 25
$2.4B
$2.3B
Q3 25
$2.1B
$2.4B
Q2 25
$2.6B
$2.5B
Q1 25
$2.1B
$1.8B
Q4 24
$2.5B
$2.0B
Q3 24
$2.6B
$2.1B
Q2 24
$3.0B
$1.8B
Debt / Equity
BLKB
BLKB
INSM
INSM
Q1 26
Q4 25
13.06×
0.74×
Q3 25
0.58×
Q2 25
0.44×
Q1 25
11.31×
Q4 24
8.50×
3.93×
Q3 24
1.84×
2.01×
Q2 24
1.78×
30.66×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLKB
BLKB
INSM
INSM
Operating Cash FlowLast quarter
$51.5M
$-247.6M
Free Cash FlowOCF − Capex
$37.0M
$-264.2M
FCF MarginFCF / Revenue
13.2%
-100.1%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$294.1M
$-967.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLKB
BLKB
INSM
INSM
Q1 26
$51.5M
Q4 25
$58.0M
$-247.6M
Q3 25
$139.2M
$-219.8M
Q2 25
$66.9M
$-205.6M
Q1 25
$1.4M
$-262.1M
Q4 24
$73.6M
$-196.0M
Q3 24
$104.0M
$-180.9M
Q2 24
$53.1M
$-123.0M
Free Cash Flow
BLKB
BLKB
INSM
INSM
Q1 26
$37.0M
Q4 25
$55.0M
$-264.2M
Q3 25
$135.7M
$-222.2M
Q2 25
$66.3M
$-209.1M
Q1 25
$712.0K
$-272.2M
Q4 24
$73.4M
$-202.8M
Q3 24
$102.9M
$-184.6M
Q2 24
$48.0M
$-129.7M
FCF Margin
BLKB
BLKB
INSM
INSM
Q1 26
13.2%
Q4 25
18.6%
-100.1%
Q3 25
48.3%
-156.1%
Q2 25
23.5%
-194.6%
Q1 25
0.3%
-293.2%
Q4 24
24.3%
-194.1%
Q3 24
35.9%
-197.6%
Q2 24
16.7%
-143.6%
Capex Intensity
BLKB
BLKB
INSM
INSM
Q1 26
Q4 25
1.0%
6.3%
Q3 25
1.2%
1.7%
Q2 25
0.2%
3.2%
Q1 25
0.3%
10.8%
Q4 24
0.1%
6.5%
Q3 24
0.4%
3.9%
Q2 24
1.8%
7.5%
Cash Conversion
BLKB
BLKB
INSM
INSM
Q1 26
1.65×
Q4 25
1.58×
Q3 25
2.93×
Q2 25
2.53×
Q1 25
0.32×
Q4 24
Q3 24
5.69×
Q2 24
2.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons